Article Text

Download PDFPDF
Original research article
Direct oral anticoagulation and mortality in moderate to high-risk atrial fibrillation
  1. Ronen Arbel1,
  2. Ruslan Sergienko2,
  3. Ariel Hammerman3,
  4. Sari Dotan-Greenberg3,
  5. Erez Batat3,
  6. Orly Avnery4,
  7. Dan Greenberg2,
  8. Martin H Ellis4
  1. 1 Maximizing Health Outcomes Research Lab, Sapir College, Sderot, Israel
  2. 2 School of Public Health, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel
  3. 3 Clalit Health Services Headquarters, Tel Aviv, Israel
  4. 4 Hematology Institute and BloodBank, Meir Medical Center, Kfar Saba, Israel
  1. Correspondence to Dr Ronen Arbel, Sapir College, Hof Ashkelon 79165, Israel; ronen.arbel{at}gmail.com

Footnotes

  • Contributors RA: conception of the research; drafting the manuscript for critically important intellectual content; interpretation of data. RS: data analysis; revising the manuscript for critically important intellectual content. AH: conception of the research; acquisition of data; drafting the manuscript for critically important intellectual content; interpretation of data. SDG: conception of the research; revising the manuscript for critically important intellectual content. EB: conception of the research; acquisition of data. OA and MHE: interpretation of data; revising the manuscript for critically important intellectual content. DG: conception of the research; securing the funding for the research; revising the manuscript for critically important intellectual content.

  • Funding This study was supported in part by a non-restricted grant from the Israeli National Institute for Health Policy Research (Grant No 029-13).

  • Competing interests None declared.

  • Ethics approval The study was approved by Clalit Health Services’s (CHS) data extraction committee and ethical approval was provided by the Institutional Review Board of CHS.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Patient consent for publication Not required.

View Full Text

Statistics from Altmetric.com

Footnotes

  • Contributors RA: conception of the research; drafting the manuscript for critically important intellectual content; interpretation of data. RS: data analysis; revising the manuscript for critically important intellectual content. AH: conception of the research; acquisition of data; drafting the manuscript for critically important intellectual content; interpretation of data. SDG: conception of the research; revising the manuscript for critically important intellectual content. EB: conception of the research; acquisition of data. OA and MHE: interpretation of data; revising the manuscript for critically important intellectual content. DG: conception of the research; securing the funding for the research; revising the manuscript for critically important intellectual content.

  • Funding This study was supported in part by a non-restricted grant from the Israeli National Institute for Health Policy Research (Grant No 029-13).

  • Competing interests None declared.

  • Ethics approval The study was approved by Clalit Health Services’s (CHS) data extraction committee and ethical approval was provided by the Institutional Review Board of CHS.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Patient consent for publication Not required.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.